Seven questions raised by Medtronic's $43B Covidien acquisition
June 18, 2014 by Brad Perriello
AtheroMed Inc.
Volcano closes $117M AtheroMed buy
M&A: Volcano acquires AtheroMed for $115M
AtheroMed wins 510(k) clearance for atherectomy catheter
AtheroMed secured 510(k) clearance from the FDA for its Phoenix device, an atherectomy catheter used for treating peripheral artery disease.
The low-profile catheter aims to minimizes vessel interaction and designed to be easy to set up. The Phoenix system features front-cutting technology that cuts while clearing away clearing debris with an internal Archimedes screw, which runs the length of the catheter. The device is available in a variety of sizes, according to a press release.
AtheroMed closes in on $4.5M for PAD treatment
AtheroMed is closing in on a $4.5 million fundraising round, offering debt and options offering, SEC documents show.
The Menlo Park, Calif.-based medical device company has so far raised $4.3 million for its operations, according to a regulatory filing.
Stealthy AtheroMed raises $6M for peripheral atherectomy device
AtheroMed said it’s raised a $6 million equity round, taking its total funding raise since 2009 to $20 million, according to regulatory filings.
The Menlo Park, Calif.-based medical device company is developing an atherectomy device for treating peripheral artery disease, according to its website.
AtheroMed is still flying under the radar, to judge by the 1-page website, which provides only an email link to contact the company.
